Large gap with delayed quotes
|
Last quote
12/30/2024 -
17:30:19
|
Bid
12/30/2024 -
17:18:05
|
Bid Volume |
Ask
12/30/2024 -
17:19:52
|
Ask Volume |
|---|---|---|---|---|
|
19.98
-0.98
(
-4.68% )
|
20.00
|
602 |
20.12
|
211 |
Analysis date: 27.12.2024
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 10.12.2024.
Interest
Very weak
Very weak
Very weak interest since 13.12.2024.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 13.12.2024 at a price of 25.06.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, at its current price the stock is strongly overvalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 15.11.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is
4wk Rel Perf
-29.77%
-29.77%
The four week relative underperformance versus STOXX600 is 29.77%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 18.10.2024.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.44%.
Mkt Cap in $bn
0.32
0.32
With a market capitalization <$2bn, DOCMORRIS AG is considered a small-cap stock.
G/PE Ratio
1.79
1.79
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
-9.85
-9.85
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
17.58%
17.58%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
42
42
For 1% of index variation, the stock varies on average by 0.42%.
Correlation
0.08
0.08
Stock movements are totally independent of index variations.
Value at Risk
3.17
3.17
The value at risk is estimated at CHF 3.17. The risk is therefore 15.14%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
12.12.2017
12.12.2017